NCT07101224已完成不适用
Data Registry in Chinese Hemophilia A and B Patients Related to the Use of Anti-hemophilic Coagulation Factor Replacement Therapy
Institute of Hematology & Blood Diseases Hospital, China1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2017年5月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- The incidence of MIEs and other SAEs
研究概览
简要总结
This is an open-label, prospective, multi-center, patient registry in Chinese Hemophilia A and B patients treated with anti-hemophilic coagulation factor replacement therapy.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •Unwilling or unable to follow the terms of the protocol.
结局指标
主要结局
The incidence of MIEs and other SAEs
时间窗: at the end of 2 year data registry
The incidence of MIE(medically important events)s and other SAE(serious adverse event)s in the anti-hemophilic replacement treatment
次要结局
- Treatment regimen(at the end of 2 year data registry)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual UseHemophilia BNCT00167973Wyeth is now a wholly owned subsidiary of Pfizer218
Unknown
不适用
Turkish Acquired Haemophilia RegistryAcquired HaemophiliaNCT01403740Turkish Society of Hematology250
招募中
不适用
Pulmonary Hypertension Observational StudyPulmonary HypertensionNCT05958901The First Affiliated Hospital of Guangzhou Medical University10,000
招募中
不适用
Chinese Atrial Fibrillation RegistryAtrial Fibrillation (AF)NCT06987825Beijing Anzhen Hospital100,000
Unknown
不适用
Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure TechnologyNon-valvular Atrial FibrillationNCT03917563Xijing Hospital1,050